Cervical cancer is the third most common cancer and fourth most common cause of cancer related deaths in female population, accounting to approximately 453,300 cases per year and 275,100 deaths in the year 2008. According to the latest WHO global cancer statistics, the cumulative risk (%) (Age 0-74) of cervical carcinoma is 0.9 with age adjusted ratio of 9.0 (Jemal et al., 2011). In India, cerv...

BACKGROUND Despite the increasing number of screening examinations performed for cervical cancer utilizing the Papanicolaou smear test (Pap test), few studies have examined whether this strategy is cost-effective in Korea. OBJECTIVE This study was conducted to evaluate the cost-effectiveness of cervical cancer screening strategies incorporating the Pap test based on age at the start and end o...

A randomised controlled trial conducted in Mumbai, India, compared invasive cervical cancer rates among women offered cervical screening with invasive cervical cancer rates among women offered no-screening. The US Office for Human Research Protections determined the Mumbai trial was unethical because informed consent was not obtained from trial participants. Reportedly, cervical screening in th...

Background: Beliefs of women play a very important role in efficacy of screening for cervical cancer. Therefore, it is necessary to investigate their points of view using appropriate tools with suitable validity and reliability. It seems that the Pap Smear Belief Questionnaire (PSBQ) can assess the attitudes and beliefs of women towards screening for Pap smear. Aim: This study aimed to evaluate...

In limited resource settings such as Rwanda, visual inspection with acetic acid (VIA) is the primary model for cervical cancer screening. The objective of this study was to describe clinical characteristics and outcomes for women presenting for cervical cancer screening. A prospective, observational study was conducted between September 2015 and February 2016 at Kigali University Teaching Hospi...

Recommendations for cervical cancer screening have had remarkable agreement from a number of medical societies, including the American College Obstetricians and Gynecologists (ACOG), Cancer Society (ACS), Cervical Colposcopy Pathology (ASCCP), US Preventative Services Task Force (USPSTF). Reference to recommended age may need be re-examined, in light current data regarding comparative age-relat...

OBJECTIVE Access to cervical cancer screening may be lower among lower income and socially disadvantaged populations. However, few studies have specifically examined factors associated with cervical cancer screening among socially marginalized populations, especially in settings with free health care systems. METHODS The present study was conducted to examine the prevalence and correlates of ...

The incidence rate of cervical cancer in Korea is still higher than in other developed countries, notwithstanding the national mass-screening program. Furthermore, a new method has been introduced in cervical cancer screening. Therefore, the committee for cervical cancer screening in Korea updated the recommendation statement established in 2002. The new version of the guideline was developed b...

OBJECTIVE The National Cancer Screening Program (NCSP) began in 1999. In this report, we evaluate the results of the NCSP for cervical cancer in 2009 and provide participation rates in an organized cervical cancer screening program in Korea. METHODS Using data obtained from the National Cancer Screening Information System, cervical cancer screening participation rates were calculated. Recall ...

BACKGROUND Use of the Pap test has resulted in a decline in cervical cancer mortality in developed countries. Yet, despite established cervical cancer screening programs, a significant portion of Jamaican women are not undergoing screening for cervical cancer. This study was carried out to identify factors that affect Jamaican women's decisions to screen for cervical cancer. METHODS A populat...